AlphaQuest’s Pacira BioSciences PCRX Stock Holding History

AlphaQuest’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,304	Closed	-$241K	–	1474
2025 Q4	$241K	Sell	9,304 -2,941	-24%	-$69.9K	0.01%	1355
2025 Q3	$316K	Sell	12,245 -2,293	-16%	-$56.3K	0.02%	1124
2025 Q2	$347K	Sell	14,538 -4,982	-26%	-$126K	0.03%	802
2025 Q1	$485K	Buy	19,520 +6,027	+45%	+$144K	0.05%	532
2024 Q4	$254K	Buy	13,493 +4,083	+43%	+$71.7K	0.03%	775
2024 Q3	$142K	Buy	9,410 +5,449	+138%	+$93.2K	0.01%	1196
2024 Q2	$113K	Buy	+3,961	New	+$113K	0.02%	900
2024 Q1	–	Sell	-3,711	Closed	-$125K	–	1761
2023 Q4	$125K	Buy	+3,711	New	+$109K	0.03%	721

Other funds holding PCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return